DONATE

IBEC organized the conference “The Future of Personalized Medicine” as part of the Complementary Plan for Biotechnology Applied to Health

Last Friday, the conference took place in Barcelona, bringing together over 100 attendees from the biomedical research field in Spain. Representatives from the Department of Health and Research and Universities of the Catalan Government were also present.

Samuel Sanchez receives the Constantes y Vitales Award

IBEC researcher Samuel Sánchez has been honored with the 2023 Constantes y Vitales Award in the “Young Talent in Biomedical Research” category for his work on designing self-propelled nanorobots capable of delivering drugs within the human body. This initiative, presented by LaSexta and AXA Foundation, aims to foster biomedical research in Spain and spotlight the contributions of its scientists.

Bioengineering for future medicine in the 16th IBEC Symposium

IBEC’s 16th annual Symposium focused on ‘Bioengineering for Future and Precision Medicine,’ one of IBEC’s three key application areas. Approximately 300 people attended the event, including local and international researchers. It provided a multidisciplinary environment where experts from other institutions and the IBEC community had the opportunity to present their projects and exchange knowledge.

IBEC showcases its technological capabilities to foster new partnerships at BIOSPAIN

IBEC showcases its technological capabilities to foster new partnerships at BIOSPAIN. IBEC representatives actively participated in the BIOSPAIN conference, seizing the opportunity to highlight the institute’s advancements in science and technology. Over the three days of the event, they presented various aspects, ranging from basic research to the coordination of state plans and technology transfer conducted at IBEC. BIOSPAIN, a premier congress in Europe, brings together more than 850 innovative entities specializing in health, sustainable agri-food practices, and solutions against climate change.

European funding for the treatment of Type 1 diabetes using 3D bioprinting

IBEC researcher Javier Ramón Azcón has been awarded an “ERC Proof of Concept Grant.” This prestigious funding is granted by the European Research Council to explore the commercial and societal potential of research projects conducted in European institutions. Ramón’s project, Uniink, is centered on the treatment of Type 1 diabetes using cell therapy and 3D bioprinting.

Samuel Sánchez Receives ERC Proof of Concept Grant to Target Mucinous Tumors with his Nanorobots

Samuel Sánchez has successfully secured an “ERC Proof of Concept” grant, provided by the European Research Council (ERC), to explore the application of his nanorobots in the treatment of mucus-secreting tumors. This prestigious grant enables researchers to assess the feasibility and potential for knowledge transfer of their research projects.